To determine the relative effectiveness of intra-arterial thrombolysis compared to surgery for the treatment of lowerlimb ischaemia.
Participants included in the review
People with lower-limb ischaemia. In the individual studies, inclusion criteria were people who had lower-limb ischaemia of less than six months duration or patients with acute lower limb peripheral artery occlusion of less than 14 -30 days duration.
Outcomes assessed in the review
Adverse events such as death/major amputation and post-intervention wound complications. Also mortality, amputation ischaemia, and life-threatening haemorrhage. Mean length of hospital stay and duration of ischaemia was also evaluated in some studies.
How were decisions on the relevance of primary studies made?
The authors do not state how the papers were selected for the review, or how many of the reviewers performed the selection.
Assessment of study quality
The quality of the included studies was determined using a proforma based on the CONSORT statement (see Other Publications of Related Interest nos.1-2) and Cochrane Collaboration checklists. The proforma graded studies for inclusion by assessment of: method of randomisation and degree of blinding; comparability of groups in control and intervention arms at baseline; the analysis of results on an intention to treat basis; completeness of follow-up; the blinding and objectivity of outcome assessment; the appropriateness and completeness of statistical analysis of results, including sensitivity analysis. The authors do not state how the papers were assessed for quality, or how many of the authors performed the quality assessment.
